Anti-HIV compound assessment by two novel high capacity assays
about
(-)-2'-deoxy-3'-thiacytidine is a potent, highly selective inhibitor of human immunodeficiency virus type 1 and type 2 replication in vitro6-Methoxypurine arabinoside as a selective and potent inhibitor of varicella-zoster virusAnti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cellsSelective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosineInfluence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides5-Chloro-2',3'-dideoxy-3'-fluorouridine (935U83), a selective anti-human immunodeficiency virus agent with an improved metabolic and toxicological profileSynthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94)1592U89, a novel carbocyclic nucleoside analog with potent, selective anti-human immunodeficiency virus activityA rapid method for screening large numbers of environmental microorganisms for antiviral activityAntiviral, metabolic, and pharmacokinetic properties of the isomeric dideoxynucleoside 4(S)-(6-amino-9H-purin-9-yl)tetrahydro-2(S)-furanmethanol.Antiviral activity of GW678248, a novel benzophenone nonnucleoside reverse transcriptase inhibitorPhosphoramidate protides of 2',3'-dideoxy-3'-fluoroadenosine and related nucleosides with potent activity against HIV and HBV.Synthesis of carbocyclic analogs of 2',3'-dideoxysangivamycin, 2',3'-dideoxytoyocamycin, and 2',3'-dideoxytriciribine.Phosphoramidate protides of carbocyclic 2',3'-dideoxy-2',3'-didehydro-7-deazaadenosine with potent activity against HIV and HBV.
P2860
Q28316326-E1162D31-DCE8-41B2-B40F-9E14DC4D6F5CQ28321395-AC863C4C-D259-4236-B2ED-B7755C1E6B44Q28323830-3E1D039F-DA76-44A8-812A-FA1276D3D714Q28342752-BE6B04AA-743C-436E-AFCE-6B640F89BC84Q28367580-0932804C-4314-460E-A341-AA19F9AF4300Q28367605-334E4988-4CBD-4D65-B608-721E687AF3CBQ28377193-AC0F1337-4AE4-4841-B927-EA68BDBAC564Q28378894-2BD7F527-468D-4530-B575-E46970D4BD10Q33713746-F5B0006D-FAAE-46F0-91BB-44D4DAF1F77FQ35118261-293D6D90-0DD8-4485-8664-732DC088FDACQ40367975-E212B1F7-E613-4236-846A-2877A60814F5Q40618080-919A4698-FD63-4E85-8C60-842EDD6F6C9DQ43806920-1D59DAB6-77E8-4AFE-8495-FFFE35E19F45Q45208901-5253B3E2-EB15-4304-9EB8-477903B249F1
P2860
Anti-HIV compound assessment by two novel high capacity assays
description
1989 nî lūn-bûn
@nan
1989 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1989 թվականի մարտին հրատարակված գիտական հոդված
@hy
1989年の論文
@ja
1989年論文
@yue
1989年論文
@zh-hant
1989年論文
@zh-hk
1989年論文
@zh-mo
1989年論文
@zh-tw
1989年论文
@wuu
name
Anti-HIV compound assessment by two novel high capacity assays
@ast
Anti-HIV compound assessment by two novel high capacity assays
@en
Anti-HIV compound assessment by two novel high capacity assays
@nl
type
label
Anti-HIV compound assessment by two novel high capacity assays
@ast
Anti-HIV compound assessment by two novel high capacity assays
@en
Anti-HIV compound assessment by two novel high capacity assays
@nl
prefLabel
Anti-HIV compound assessment by two novel high capacity assays
@ast
Anti-HIV compound assessment by two novel high capacity assays
@en
Anti-HIV compound assessment by two novel high capacity assays
@nl
P1476
Anti-HIV compound assessment by two novel high capacity assays
@en
P2093
D R Averett
P304
P356
10.1016/0166-0934(89)90159-6
P407
P577
1989-03-01T00:00:00Z